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Abstract 
Cerebral microbleeds (CMBs) identified by in vivo magnetic resonance imaging (MRI) of brains of older persons 
may have clinical relevance due to their association with cognitive impairment and other adverse neurologic 
outcomes, but are often not detected in routine neuropathology evaluations. In this study, the utility of ex vivo 
MRI in the neuropathological identification, localization, and frequency of CMBs was investigated. The study 
included 3 community dwelling elders with Alzheimer’s dementia, and mild to severe small vessel disease (SVD). 
Ex vivo MRI was performed on the fixed hemisphere to identify CMBs, blinded to the neuropathology diagnoses. 
The hemibrains were then sliced at 1 cm intervals and 2, 1 or 0 microhemorrhages (MH) were detected on the 
cut surfaces of brain slabs using the routine neuropathology protocol. Ex vivo imaging detected 15, 14 and 9 
possible CMBs in cases 1, 2 and 3, respectively. To obtain histological confirmation of the CMBs detected by ex 
vivo MRI, the 1 cm brain slabs were dissected further and MHs or areas corresponding to the CMBs detected by 
ex vivo MRI were blocked and serially sectioned at 6 µm intervals. Macroscopic examination followed by micros-
copy post ex vivo MRI resulted in detection of 35 MHs and therefore, about 12 times as many MHs were detected 
compared to routine neuropathology assessment without ex vivo MRI. While microscopy identified previously 
unrecognized chronic MHs, it also showed that MHs were acute or subacute and therefore may represent peri-
mortem events. Ex vivo MRI detected CMBs not otherwise identified on routine neuropathological examination 
of brains of older persons and histologic evaluation of the CMBs is necessary to determine the age and clinical 
relevance of each hemorrhage.  
 
Keywords: Alzheimer’s dementia, Cerebral microbleeds, Ex vivo magnetic resonance imaging, Hemosiderin, Microhemorrhages 
 
Original Paper 
Free Neuropathology 2:35 (2021) Nag et al 





Cerebral microbleeds (CMBs) are defined as 
rounded or ovoid, hypointense foci that are best 
demonstrated in susceptibility-weighted and gradi-
ent echo magnetic resonance imaging (MRI). In most 
studies, the upper limit of the diameter of CMBs is 
5-5.7 mm [1-3], although a diameter of 10 mm has 
also been reported [4]. Neuroimaging studies show 
that CMBs tend to increase with age being observed 
in 5% of healthy adults [5, 6], and 7% of volunteers 
having a mean age of 62.1 ±7.4 years who were en-
rolled in the UK Biobank study [7]. CMBs are re-
ported in 18% of subjects between 60 to 69 years, 
while in those older than 80 years prevalence in-
creases to 38% [6]. CMBs have also been associated 
with increased risk of stroke in the general popula-
tion [8]. Prevalence is higher in those with ischemic 
stroke and with non-traumatic intracerebral hemor-
rhage, being 34% and 60%, respectively [5]. In the 
latter study, CMBs were associated with hyperten-
sion or diabetes mellitus in otherwise healthy adults, 
while in adults with cerebrovascular disease they 
were only associated with hypertension. The fre-
quency of CMBs is 84.9% in those with subcortical 
vascular dementia and in these subjects CMBs were 
related to cognitive impairment in multiple domains 
[9].  
In most studies, CMBs were identified by in 
vivo MRI alone [8-12], while in a few studies by neu-
ropathology assessment alone in which they are re-
ferred to as microhemorrhages (MHs) [13]. The de-
velopment of ex vivo MRI led to studies correlating 
ex vivo MRI findings with neuropathology in se-
lected brain slabs [1, 2, 14-16]. In these studies, 
CMBs were considered to be markers of focal hemo-
siderin deposition that remained in macrophages for 
years following a MH [1, 11]. There is increasing evi-
dence that the pathologic correlate of CMBs is more 
varied than just MHs since a significant association 
was observed between hemosiderin collections in 
the putamen and indices of small vessel ischemia 
such as microinfarcts, arteriolosclerosis and lacunes 
in any of the brain regions examined [2, 14].  
The aim of the present study was to character-
ize the morphologic correlate of CMBs identified by 
ex vivo MRI of a single cerebral hemisphere of 3 
brains with and without MHs identified on initial 
neuropathology assessment. This was followed by 
detailed neuropathology assessment to determine 
the spectrum of pathology associated with the CMBs 
identified by ex vivo MRI. Since one in five patients 
with Alzheimer’s disease (AD) has CMBs [17], and 
the frequency of CMBs is higher in association with 
cerebral amyloid angiopathy (CAA) [2, 18], and arte-
riolosclerosis [1, 19], 3 community dwelling elders 
with a clinical diagnosis of Alzheimer’s dementia and 
varying degrees of small vessel disease (SVD) were 
selected for assessment.  
Materials and methods 
The criteria for selection of the three autopsied 
cases for this study include a clinical diagnosis of Alz-
heimer’s dementia and pathologic evidence of CAA 
and arteriolosclerosis as well as absence of a clinical 
history of traumatic brain injury with loss of con-
sciousness since diffuse axonal injury following head 
trauma is another potential secondary cause of CMB 
[11]. Cases were from the Memory and Aging Pro-
ject (MAP), a large clinical-pathology study of aging 
and dementia with community dwelling partici-
pants. The protocols used in this study were ap-
proved by the Institutional Review Board of Rush 
University Medical Center. A signed informed con-
sent was obtained from each participant for an an-
nual clinical evaluation and for brain donation. Par-
ticipants underwent uniform clinical evaluations at 
baseline and annually thereafter for odor testing, 
parkinsonism signs and cognitive function as de-
scribed previously [20].  
Ex vivo imaging 
Following removal, the brain was hemisected 
and one hemisphere with visible gross pathology or 
one hemisphere with absence of pathology was se-
lected arbitrarily and submerged medial side up in 4 
% paraformaldehyde in a container which was 
rocked back and forth until no more air bubbles es-
caped from the lateral ventricles. The hemisphere 
was then placed medial side down and refrigerated. 
MRI was done on average 1 month postmortem on 
hemibrains returned to room temperature, im-
mersed in 10% formalin and held in place in a con-
tainer using a plastic divider. Ex vivo MRI was done 
using a Siemens 3Tesla MRI scanner and a three- 
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Table 1: Clinical and pathological findings in 3 cases with a 
clinical diagnosis of Alzheimer’s dementia. 
 Case 1 Case 2 Case 3 
Age, years 91.4 96.2 79.2 
Sex Female Female Male 
Education, years 16 12 16 
Blood pressure, mm 
Hg (last valid) 
96/54a 171/96b M 
MMSE score (last valid) 11a 5b 9c 
Total CMBs detected 
by ex vivo MRI 
15 14 9 
 
Post mortem interval, 
hours 
22 8 6 
 
Pathological Diagnoses from blocks taken routinely 
Alzheimer’s Disease  - + + 
   CERAD Probable Probable Definite 
   Braak stage I III IV 
   Thal stage 3 3 5 




Hippocampal Sclerosis + - - 
LATE-NC - Stage 3 3 0 
Cerebral amyloid angi-
opathy, mild-severe 
Mild Mild Severe 
Arteriolosclerosis Mild Mod- 
Severe 
Mild 




- 4 1 
Microscopic infarcts, 
chronic 
- 7 1 
Total MHs using the 
routine protocol 
(no ex vivo MRI) 
2 1 0 
Total MHs post ex vivo MRI 
  Acute 5 2 5 
  Subacute 9 0 0 
  Chronic 1 12 1 
Additional pathologies in blocks taken post ex vivo MRI 
Microinfarct, chronic - 1 1 
Microinfarct, subacute 0 1 0 
Abbreviations: ADNC - Alzheimer’s disease neuropathologic 
change; CERAD - Consortium to establish a registry for Alz-
heimer’s disease; CMBs - cerebral microbleeds; LATE-NC - limbic 
predominant age-related TDP-43 neuropathologic change; M - 
missing; MHs - microhemorrhages; Mod - moderate.  
Values obtained 3a, 7b and 4c months prior to death. 
 
dimensional multi-echo gradient echo (GRE) se-
quence with 6 echoes (TE = 5 + n×5 ms (n=0-5), TR = 
35 ms), an acquired voxel-size of 1×1×1 mm3, and a 
scan time of about 8 min. Microbleeds were identi-
fied by a trained reader who was blinded to clinical 
and pathology data. CMBs were diagnosed when a 
relatively round, small, hypointense region of few 
mm in diameter was observed on the last echo of 
the GRE data. At least half of the hypointensity had 
to be surrounded by brain parenchyma to qualify. 
Elongated, vessel-like hypointensities and potential 
mimics, including lesions in the subarachnoid space, 
calcifications, or vascular malformations were ex-
cluded. 
Neuropathology assessment 
The mean postmortem interval for cases 1-3 
was 22, 8 and 6 hours, respectively (Table 1). A 
standard protocol was used to evaluate brains which 
included cutting each hemibrain into 1 cm coronal 
slabs guided by a plexiglass jig and brain blocks from 
eleven brain regions and any MH noted on the cut 
surfaces of the slabs were blocked for microscopy as 
described previously [21]. Pathological diagnosis of 
AD, hippocampal sclerosis (HS), limbic predominant 
age-related TDP-43 encephalopathy neuropatho-
logic change (LATE-NC), macroscopic and micro-
scopic infarcts were made as described previously 
[21]. CAA was assessed in meningeal and intracorti-
cal vessels in sections from the midfrontal, midtem-
poral, inferior parietal and occipital cortices which 
were immunostained for β-amyloid and graded as 
described previously [22]. Arteriolosclerosis was as-
sessed in the basal ganglia and graded using a semi-
quantitative scale from 0 (none) to 6 (severe) as de-
scribed previously [21]. 
Microhemorrhages 
The ex vivo MRI images were superimposed on 
photomicrographs of the brain slabs to identify the 
region of the suspected CMB. In this protocol, each 
1 cm slab was further dissected to detect the CMBs 
observed in the ex vivo MR images and brain blocks 
containing these CMBs were obtained. In instances 
where a MH was not identified on the cut surface of 
the brain slab, a block was obtained in the region 
containing the CMB identified by ex vivo MRI. All 
brain blocks were processed using standard tech-
niques and embedded in paraffin. Each block was se-
rially sectioned at 6µm thickness to obtain 200-250 
serial sections from each block. Every 10th section 
was stained with hematoxylin and eosin (HE) and  
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Figure 1: Ex vivo MRI scans, corresponding brain slabs and microscopy of acute and subacute hemorrhages are shown. (A) The MRI scan 
shows a CMB in the white matter of the temporal lobe (arrowhead). (B) The corresponding brain slab was further sliced in the area of the 
CMB shown in the ex vivo MR scan and delineated by the rectangle to detect the MH which is shown in the inset (case 1, MH#6). (A, B) 
Also present is another CMB at the interface of the cortex and white matter of the superior temporal gyrus (case 1, MH#8). (C) Microscopy 
of a hematoxylin and eosin (HE) stained section from MH#6 shows an acute hemorrhage with extravasation of red blood cells through a 
venular wall into the surrounding brain. (D) This MH shows no macrophages or hemosiderin by the Perl’s Prussian blue stain at this level 
or in serial sections. (E) Ex vivo MRI shows a CMB in the white matter of the inferior parietal lobule (arrowhead). (F) Further slices of the 
corresponding brain slab in the area delineated by a rectangle shows a MH (case1, MH#14) in the white matter which is shown in the 
inset. (G) An HE stained section of the MH shows significant extravasation of red blood cells through an arteriolar wall (arrowhead) into 
the neuropil. A few pigment-laden macrophages are identified at the periphery of the hemorrhage (inset). (H) The increased number of 
macrophages are clearly evident by the Perl’s Prussian blue stain. Higher magnification of the hemosiderin positive macrophages is shown 
in the inset. C, D, G, H scale bar = 50 µm; insets G, H scale bar = 10 µm
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the adjacent section was stained by the Perl’s Prus-
sian blue stain for hemosiderin. In select cases, ad-
ditional sections were stained by HE and for hemo-
siderin. Immunohistochemistry to detect β-amyloid 
was done in all CMB’s as described previously [22]. 
The size of MHs was measured using a 1 mm grati-
cule at a magnification of x100. 
Results 
The age of the three decedents was 91.4, 96.2 
and 79.2 years and in keeping with the clinical diag-
nosis of Alzheimer’s dementia, all cases had a low 
Mini-Mental State Examination score which varied 
from 5-11 (Table 1). Blood pressure data was only 
available for 2 cases and only case 2 was hyperten-
sive. On routine neuropathology assessment, (Table 
1) two of the three cases had intermediate likeli-
hood of AD by the NIA-Reagan and ADNC criteria 
while the third case with low likelihood of AD had 
hippocampal sclerosis with LATE-NC (stage 3) imply-
ing involvement of the amygdala, limbic and neocor-
tical areas by TDP-43 neuronal and glial cytoplasmic 
inclusions. Regarding vascular changes, cases 1 and 
2 had mild CAA while case 3 had severe CAA. Arteri-
olosclerosis was mild in cases 1 and 3 and moderate-
severe in case 2.  
Ex vivo imaging detected 15,14 and 9 possible 
CMBs in cases 1, 2 and 3, respectively (Table 1). MR 
images showed hypointense, rounded areas in the 
gray or white matter which were interpreted as 
CMBs. (Fig. 1A, E, 2A) The diameter of CMBs meas-
ured in the same echo as used for their visualization, 
varied from 1.56 – 4.20 mm. Most of the CMBs ob-
served in this study were located in the subcortical 
white matter near the grey/white junction of the 
frontal, temporal or occipital lobes, although, in-
volvement of gray matter structures such as the 
midtemporal cortex, thalamus and caudate nucleus 
were also noted.  
Macroscopic findings 
The appearance of the MHs on macroscopic ex-
amination of the cut surfaces of brain slabs whether 
using the routine or the extended protocol was simi-
lar. MHs appeared as rounded, reddish areas, 1-2 
mm in diameter resembling the MH shown in the in-
set of Fig. 1B. In a few cases, there was a focal area 
of bluish discoloration suggesting presence of a 
hemorrhage below the cut surface of the brain slab 
while in other cases no hemorrhage was noted on 
the cut surface of the slab and was only identified 
following serial sectioning in the regions showing 
CMBs by ex vivo imaging (Fig. 1F). 
Microscopic findings 
A total of 12 acute, 9 subacute and 14 MHs 
were identified by microscopy of the 3 cases which 
include the 3 MHs observed using routine neuropa-
thology assessment. Most of the hemorrhages 
(74%) were located in the white matter while the re-
mainder were in grey matter structures such as one 
in the midtemporal cortex, one in the caudate nu-
cleus and others in the thalamus (Table 2). Micros-
copy of all 35 MHs showed that their diameter var-
ied from 0.2-0.8 mm. Most MHs were associated 
with arterioles. Among the acute hemorrhages, 3 
were associated with venules and 1 with multiple ca-
pillaries. In the case of chronic hemorrhages, only 
one was associated with a venule, while another 
chronic hemorrhage was associated with both an ar-
teriole and venule which were adjacent to each 
other, while others were associated with arterioles. 
On serial sectioning, MHs involved variable lengths 
of the vessel with some MHs involving short 125-300 
µm segments of arterioles while others involved 
long segments of arterioles varying from 480-780 
µm in length. There was no evidence of calcification 
or vascular malformations, such as a cavernous he-
mangioma in any of the sections examined. Most 
blocks showed a single MH correlating with the CMB 
seen on ex vivo MRI, however, there were 3 in-
stances when the block showed additional MHs 
which were not identified by ex vivo MRI (Table 2).  
MHs were acute, subacute or chronic based on 
the cellular response present. Acute MHs showed 
extravasation of erythrocytes through the walls of 
mainly arterioles and fewer venules and extended 
into the surrounding neuropil (Fig. 1C). Serial sec-
tioning of the entire block did not show inflamma-
tory cells or hemosiderin either on HE or the Perl’s 
Prussian blue stain thus their age was not altered 
(Fig. 1D). An additional finding in subacute MHs was 
the extension of red blood cells further from vessel 
walls than observed in the acute hemorrhages (Fig. 
1G). A few intravascular and a variable number of  
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Table 2: Location and age of microhemorrhages (MH) detected without MRI and pathological features of those detected following ex vivo 
MRI. 
 MH diagnosis by 
routine NP 
CMBs diagnosed following 










1  Superior frontal, WM Acute - 1  
2  Subcortical WM, between superior 
and middle frontal gyri  
Acute - 1  
3  Inferior frontal gyrus, WM Subacute + 1  
4  Anterior temporal tip, WM Subacute  + 1  
5  Midtemporal gyrus, WM Subacute  + 2  
6  Midtemporal gyrus, WM Acute - 1  
7 Superior temporal gyrus 
WM, acute 
Superior temporal gyrus, WM Subacute + 1  
8  Superior temporal gyrus, WM Subacute + 1  
9  Superior temporal gyrus, WM Subacute  + 1  
10  Postcentral gyrus, WM Subacute + 1  
11 Inferior temporal gyrus 
WM, acute 
Inferior temp gyrus, WM Acute - 1  
12  Temporal periventricular WM No MH - 0  
13  Superior parietal lobule, WM Acute - 1  
14  Inferior parietal lobule, WM Subacute  + 1  
15  Anterior insula, WM Chronic + 1  
Case 2 
1  Occipital WM, posterior No MH - 0 Dilated vein 
with luminal 
blood 
2  Occipital WM, anterior Chronic + 1  
3 Midtemporal cortex, 
chronic 
Midtemporal cortex Chronic + 1  
4  Thalamus, (ventral posterior lateral 
nucleus) 
No MH - 0  
5  Thalamus, (lateral, posterior 
nucleus) 
Chronic + 2 Subacute 
microinfarct-1 
6   Thalamus (dorsomedial nucleus) No MH - 0  
7  Thalamus (dorsomedial nucleus near 
midline) 
No MH - 0 Dilated 
vessels with 
luminal blood 
8   WM near ventro-lateral nucleus of 
thalamus 
Chronic + 2  
9   Thalamus (ventro-lateral nucleus) Chronic + 4  
10  Thalamus (ventro-lateral nucleus) Chronic - 1 Chronic 
microinfarct-1 
11  WM ventral to putamen  (posterior) No MH - 0  
12  WM adjacent to lateral putamen Chronic + 1 Perivascular 
hemosiderin 
13   WM ventral to Putamen (anterior) Acute - 1  
14  Caudate nucleus Acute - 1  
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1 No CMB diagnosed Superior frontal gyrus No MH - 0  
2 WM lateral to Putamen No MH - 0 Dilated ves-
sels with lumi-
nal blood 
3 Frontal lobe WM Acute - 1  
4 Parietal lobe WM Acute - 1  
5 Occipitotemporal gyrus,WM Acute - 1  
6 Occipitotemporal gyrus, WM Acute - 1  
7 Occipital lobe WM Acute - 1  
8 Occipital lobe WM No MH - 0  
9 Occipital lobe WM Chronic + 1 Chronic 
microinfarct-1 




perivascular macrophages were present and many 
contained faint brown hemosiderin pigment. The 
adjacent Perl’s-stained section accentuated the 
macrophage numbers and their hemosiderin con-
tent (Fig. 1H). The neuropil surrounding the hemor-
rhage showed vacuolation and sparse gemistocytes. 
In chronic MHs, a cavity was present containing or 
surrounded by a variable number of macrophages 
which showed intense brown cytoplasmic staining 
due to hemosiderin (Fig. 2C, D). The neuropil sur-
rounding the hemorrhage showed fibrillary astro-
cytes. Adjacent arterioles showed acellular mural 
thickening with absence of smooth muscle cells and 
failed to show β-amyloid positivity (Fig. 2E). In all 
MHs, vessels failed to show mural β-amyloid positiv-
ity with the exception of one chronic MH (case 2, MH 
#3) in the midtemporal cortex which showed a dis-
rupted vessel associated with hemosiderin-laden 
macrophages (Fig. 2F) and focal β-amyloid positivity 
at the periphery of the vessel (Fig. 2G). Another pat-
tern of chronic MH was the presence of scattered 
hemosiderin-laden macrophages in a focal area of 
the white matter (Fig. 3A). Serial sectioning showed 
that these areas extended for depths of 120-180 µm 
and were related to terminal arterioles and capillar-
ies (Fig. 3B). In some MHs, arterioles with sclerosed, 
hyaline walls and collapsed lumina were present sur-
rounded by variable numbers of hemosiderin con-
taining macrophages in the neuropil. In one in-
stance, only perivascular collections of few macro-
phages were present in multifocal areas of the puta-
men.  
In addition to the MHs which correlated with 
the hypointense areas detected by ex vivo MRI, se-
rial sectioning showed MHs measuring < 0.4 mm in 
their greatest dimension (Fig. 3C, D). These MHs 
were much smaller than the CMBs identified by ex 
vivo MRI and were present in 1-3 consecutive sec-
tions per block. These small MHs were not included 
in the total MH counts shown in Table 1, since they 
did not correlate with any of the reported hy-
pointensities observed by MRI and since they were 
too small to be visualized by a 3T scanner. 
Although 38 CMBs were described in the ex 
vivo MR scans, in 8 instances microscopy did not 
show MHs despite additional slicing of brain slabs 
and microscopy of serially sectioned blocks. On mi-
croscopy, 3 of these presumed CMBs showed 2-3 
large dilated vessels with luminal blood (Table 2). In 
2 presumed CMBs, the area of hypointensity repre-
sented the site of entry of penetrating arterioles in 
the lateral and inferior portion of the putamen and 
in 2 presumed CMBs the area of hypointensity prob-
ably represented the depths of sulci and only in one 
case no pathology was detected. Additional pathol-
ogy identified by serial sectioning were chronic mi-
croinfarcts in 2 cases and a subacute microinfarct in 
1 case (Table 2) and microinfarcts measuring < 0.4 
mm in their greatest dimension (Fig. 3E, F). 
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Figure 2: Ex vivo MRI scan, corresponding brain slab and microscopy of chronic grey matter hemorrhages are shown. (A) Ex vivo MRI 
shows a CMB in the lateral thalamus. (B) The corresponding brain slab shows an area of reddish discoloration (arrowhead) which is shown 
at higher magnification in the inset (case 2 MH#8). (C) The corresponding HE stained section shows a cavity containing hemosiderin-laden 
macrophages adjacent to an arteriole which shows focal mural disruption and double-barreling. A nearby arteriole shows perivascular 
hemosiderin-laden macrophages. (D) The adjacent section shows strong Prussian blue staining of the hemosiderin collections. (E) Im-
munostaining of the arteriole shown in C and D fails to show mural β-amyloid although the double barreling is highly suggestive of CAA. 
(F) A focal hemorrhage in layer three of the superior temporal cortex shows disruption of a vessel associated with hemosiderin-laden 
macrophages which are also present in the surrounding neuropil along with gemistocytes (arrowhead) (G) The adjacent section shows 
focal β-amyloid immunostaining at the periphery of the vessel (arrowhead). C, D scale bar = 50 µm; E, G scale bar = 50 µm, F scale bar = 
50 µm. 
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Figure 3: Microscopy of chronic hemorrhages and chronic microinfarcts. (A) An example of a focal chronic white matter hemorrhage (600 
x 300 µm) showing scattered hemosiderin-laden macrophages (arrowheads). (B) The adjacent section shows a terminal arteriole (arrow-
head) and capillary (below the asterisk) with all macrophages showing positivity by the Perls’s Prussian blue stain. Serial sections show 
two small MHs (C, D) measuring 200 (C) and 300 (D) µm in their longest dimension and two chronic microinfarcts (E, F) measuring 300 (E) 
and 200 (F) µm which do not correlate with any CMBs observed in the ex vivo scans. The microinfarcts show disruption of the neuropil 
and many macrophages some of which appeared pale brown suggesting hemosiderin but were negative by the Perl’s Prussian blue stain. 
A-C scale bar = 50 µm; D-F scale bar = 50 µm. 
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This study demonstrates the utility of ex vivo 
MRI in the identification of MHs by neuropathology 
assessment. Routine macroscopic assessment 
showed a total of 3 MHs while both macroscopic and 
microscopic assessment after ex vivo MRI showed 
about 12 times as many MHs. In cases 1 and 2, the 
number of MHs was increased from that seen on 
routine neuropathology assessment, while in case 3, 
no MHs were identified on routine neuropathology 
assessment but were detected by ex vivo MRI fol-
lowed by neuropathology assessment. Thus, routine 
neuropathology assessment alone is unreliable in 
detecting the presence or the total number of MHs 
in a specific brain.  
The MHs identified in this study by microscopy 
were smaller than indicated by their MR appearance 
being < 1 mm in diameter. The finding that CMBs de-
tected by MRI appear larger on gradient-echo se-
quences compared with the actual tissue lesions is 
attributed to the “blooming effect” of the MR signal 
at the border of these lesions [11, 23]. Also, further 
shrinkage of brain blocks during the processing 
schedule for paraffin embedding may contribute to 
the reduced diameter observed on microscopy. Di-
ameters measured in ex vivo scans were reported to 
be on average 1.6 ±0.75 times [2] or 4 times [16] 
higher than the diameter identified by pathology as-
sessment. However, since the size of a CMB on MRI 
depends on imaging parameters, such as field 
strength and pulse sequence, comparison of CMB 
size across studies is probably not valid due to the 
difficulty in implementing identical imaging parame-
ters on different MRI systems [11]. The localization 
of MHs in the current study in both the grey and the 
subcortical white matter near the grey/white junc-
tion is similar to previous observations [1, 2, 13]. In 
addition, involvement of mainly arterioles and fewer 
capillaries and intracerebral venules in MHs has also 
been reported in a prior study [13]. In the current 
study, 38 blocks were examined by serial sectioning 
and 35 MHs were identified in the 3 cases with some 
blocks having more MHs than identified by ex vivo 
MRI. The very small MHs observed only by histology 
and not by ex vivo MRI in the present and previous 
studies [1, 13], are probably beyond the sensitivity 
of a 3T MRI scanner. Ex vivo imaging using a 7T scan-
ner and high resolution (200 um isotropic resolu-
tion) can detect 2.6 times as many CMBs as com-
pared to an in vivo 7T MRI scanner while ultrahigh 
resolution detects additional hypointensities which 
on microscopy show vessel pathology but no addi-
tional hemorrhages [16]. 
The criteria used in the current study for aging 
MHs as acute, subacute or chronic is supported by 
previous experimental studies of rodent [24, 25] and 
rabbit [26] brains with MHs in which the time course 
of the cellular reactions was documented. During 
the acute phase up to 48 hours, the hematoma is 
surrounded by edematous neuropil and no inflam-
matory cells. The initial peri-hemorrhage inflamma-
tory response at 48 hours consists of few blood-
borne neutrophils and brain-resident microglia 
(CX3CR1 positive) which migrate to the lesion site 
from the surrounding tissue. Astrocytic activation is 
reported to occur a few days after the onset of the 
microglial response. Conversion to hemosiderin be-
gins at day 5 after the injection of either blood or red 
blood cells into brain [26]. By day 8, macrophages 
(brain-resident microglia and fewer blood-derived 
macrophages) are abundant and show evidence of 
proliferation at the lesion site. By 2 weeks, the in-
flammatory response resolves. Therefore, subacute 
MHs are up to 2 weeks or few weeks of age. Changes 
between few weeks and 3 months are not reported, 
however, at 3 months cavities are observed at the 
MH site with variable numbers of macrophages 
showing abundant hemosiderin. Fibrillary gliosis is 
present and arterioles in the area showed mural 
thickening which is not related to amyloid as noted 
in the current and a previous study [13], while in an-
other study mural β-amyloid was detected in a 
bleeding vessel [2]. Therefore, chronic MHs are 3 
months of age or older.  
The frequency of acute MHs in the current 
study was 34%, while other studies have reported 
percentages of 26% [2] and 38% [16]. Since serial 
sections were done in the current study, the possi-
bility of focal hemosiderin deposits along the vessel 
length, that could elicit MR changes was excluded. 
The acute MHs were likely agonal as suggested pre-
viously [2]. None of the other studies have charac-
terized MHs as subacute and there seems little jus-
tification for characterizing all hemosiderin-positive 
hemorrhages with edema of the neuropil and lack of 
Free Neuropathology 2:35 (2021) Nag et al 




inflammatory changes as chronic [2, 16]. The histol-
ogy of chronic MHs observed in the current study 
was similar to previous reports [1, 2, 11]. 
Although CMBs are generally considered to be 
markers of focal hemosiderin deposits [1, 11], other 
vascular pathologies have been observed in the ar-
eas of MRI hypointensity. Two hypointensities ob-
served by susceptibility-weighted imaging were 
found to be due to a dissection in the wall of a 
grossly distended vessel and in the second case, a 
microaneurysm was present [2]. The finding that a 
distended vessel correlates with a hypointensity ex-
plains why the three hypointensities (Table 2, case 2 
#1 and #7, case 3 #2), observed in the current study 
were related to a single or several large vessel pro-
files with luminal blood. In a single study of subjects 
aged 65 and older, hemosiderin deposits which 
were considered to be the residua of MHs in the pu-
tamen, were associated with putaminal microin-
farcts suggesting that CMBs detected by MRI may be 
a surrogate for ischemic pathology rather than ex-
clusively a hemorrhagic diathesis [14]. Supporting 
these findings is the observation that three of the 
hypointensities (Table 2, case 2 #5 and #10, case 3 
#9) observed in this study showed additional mi-
croinfarcts by microscopy. In a prior study, a patho-
logic correlate for 38% of CMBs was not detected 
[1], while in the present study, no pathologic corre-
late was found for 13% of CMBs. 
Most of the MHs in this study and another large 
hospital-based autopsy study [27] were located in 
the white matter or near the grey/white junction 
where CAA is uncommon, suggesting that CAA may 
not be an etiological factor in these white matter 
MHs. Other studies [13, 27, 28] have reported lack 
of β-amyloid at the site of MHs. However, the find-
ings of focal β-amyloid immunostaining at the bleed-
ing site of one cortical arteriole in the present study, 
arterioles in a prior study [2] and increased Pittsburg 
compound B retention at the sites of CAA-related 
CMBs [29] do not rule out CAA in the etiology of 
MHs. Possibly, alteration of arteriolar morphology 
by mural β-amyloid deposition, predisposes to ves-
sel disruption and release of β-amyloid into the 
bloodstream hence the lack of β-amyloid im-
munostaining in vessels in remote chronic MHs. This 
concept explains the presence of β-amyloid up-
stream or downstream of a bleeding vessel but not 
at the hemorrhage site [28]. Vascular risk factors 
such as hypertension are associated with CMBs in 
otherwise healthy adults [5, 7, 13, 19] and in adults 
with cerebrovascular diseases [5]. Another vascular 
risk factor, severe arteriolosclerosis, is reported to 
correlate with increased numbers of cerebellar MHs 
[19]. Many of these risk factors were present in the 
3 cases in the present study as listed in Table 1. Fur-
ther studies with larger samples are warranted to 
determine the interplay of the stated factors and 
possibly additional factors in the pathogenesis of 
MHs. 
CMBs are clinically important in assessing the 
risk of cognitive impairment and high CMB counts 
are associated with an increased risk for cognitive 
deterioration and dementia [30]. Another study 
while agreeing that CMBs are associated with cogni-
tive impairment in the form of poorer executive 
function and decline in visuospatial ability, did not 
observe significant differences in incident dementia 
rates [31]. In both these studies, CMBs were diag-
nosed by in vivo MRI only. The limitations of using 
only in vivo MRI to diagnose CMBs is that MHs of dif-
ferent ages as well as hemorrhagic microinfarcts 
cannot easily be distinguished. In the present study, 
ex vivo imaging following by histology facilitated the 
detection of MHs of different ages and microin-
farcts. The limitation of a small sample size in the 
present study with only 3 cases of Alzheimer’s de-
mentia and varying degrees of SVD was offset by 
neuropathology assessment of 35 CMBs by serial 
sections and Prussian blue staining for hemosiderin. 
Hypointensities produced by anatomical landmarks 
such as the depths of sulci or the entry sites of basal 
ganglionic vessels can be excluded by making the 
MRI reader aware of these pitfalls. In summary, in 
spite of a few limitations, these data suggest that ex 
vivo imaging is useful to supplement routine neuro-
pathology examination for clinical-pathological cor-
relations in relevant autopsy cases and for research 
purposes.  
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